Arylsulfonylamino hydroxamic acid derivatives

Details Arylsulfonylamino hydroxamic acid derivatives Arylsulfonylamino hydroxamic acid derivatives

1998-08-06

2000-08-22

O'Sullivan, Peter

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

564 90, 564 91, 564 89, 5142375, 5142382, 514255, 514459, 514538, 514539, 514542, 514562, 514602, 514604, 514824, 514921, 544160, 544391, 544402, 549424, 560 13, 562430, A61K 3135, A61K 31216, A61K 3150, A61K 315375

Patent

active

061073377

ABSTRACT:
A compound of the formula ##STR1## wherein n, X, R.sup.3, R.sup.4 and Ar are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, restenosis, periodontal disease, epidermolysis bullosa, scleritis, bone resorption, loosening of artificial joint implants, atherosclerosis, multiple sclerosis, occular angiogenisis and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock and other diseases involving the production of TNF.

Affiliated with

Also associated with

Rating

Arylsulfonylamino hydroxamic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylsulfonylamino hydroxamic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonylamino hydroxamic acid derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-581620